The global medical foods market size was valued at USD 24.5 Billion in 2024, and it is expected to reach USD 37.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.78% from 2025 to 2033.
To get more information on this market, Request Sample
The global medical foods market is significantly growing due to the rising incidence of several chronic conditions such as Alzheimer’s, attention deficit hyperactivity disorder (ADHD), osteoporosis, and osteoarthritis. This promotes the need for specialized nutritional products that serve to improve the health of patients, thus aiding the market growth. Moreover, the increasing importance of dietary management of such conditions is acting as another growth-inducing inducing-factor as the medical foods enhance the quality of life by carrying an effective treatment. Additionally, the growing number of premature births in developing countries has raised the requirement for neonatal and preterm enteral feeding systems, supporting the market demand. According to the World Health Organization (WHO), there are approximately 6500 newborn deaths every day, amounting to 47% of children deaths under the age of 5 years. This has further heightened the need for medical foods globally because these products are crucial for meeting specific human nutritional requirements.
Concurrently, the market is experiencing growth driven by the increasing ubiquity of rare metabolic disorders that demand medical foods. In confluence with this, the improving healthcare costs, especially in the growing regions are allowing better access to enhanced nutritional therapies, fueling the market demand. Apart from this, the growing interest in personalized nutrition is enabling the modification of medical foods aligning with the requirements of the individuals. In addition, ongoing technological advancements in food science are providing refined formulations that can easily be broken down in the gut for easy absorption, boosting the market expansion. For example, the National Institute of Health (NIH) reports that emerging innovations in food technology utilize conventional techniques such as fermentation, extraction, encapsulation, modifying, and preserving healthy food components to eliminate enzymes and introduce new nutrients. Furthermore, the rising involvement of medical nutritionists among providers and the medical food industry to inform patients about the advantages of medical foods is significantly contributing to the market growth.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share on account of the advanced healthcare infrastructure, rising prevalence of chronic diseases, and increasing healthcare expenditure.
The market in North America is expanding due to the rising frequency of chronic diseases such as cancer, as these require additional nutrition for enhanced recovery from cachexia. In line with this, the increased awareness of medical foods among healthcare providers and patients is promoting the use of medical foods, because of their effectiveness in enhancing the outcomes of treatment. Furthermore, introducing new products and formulations for disease-specific categories is broadening their use across the region. For example, in 2024, Danone announced its acquisition of Functional Formularies, a US-based whole foods tube-feeding business, from Swander Pace Capital, aiming to support the nutritional needs of tube-fed patients. Apart from this, favorable laws and increasing expenditure on healthcare are boosting their need and making them an inevitable supplement to diets, thereby propelling the market forward.
Asia Pacific is witnessing robust growth due to rapid urbanization and lifestyle modifications. This is further triggering the incidence of metabolic disorders and malnutrition, leading to an increased demand for medical foods in the region. Moreover, social nutritional programs and the rising disposable incomes of the middle-class population is increasing their capability to spend more on healthcare, which is driving the market forward.
In Europe, the market demand is significantly driven by the aging population of the region as they depend on medical foods for ailments associated with aging, such as dementia and frailty. Additionally, favorable policies such as reimbursement for medical nutrition ensure easier access and implementation of nutrition, addressing chronic conditions, thus providing an impetus to the market.
The demand in Latin America is surging due to the growing incidence of gastrointestinal disorders and infections. This promotes the enhanced need for nutritional support in the region. Moreover, economic developments in countries like Brazil and Mexico are promoting easy access to sophisticated healthcare products, along with the rising awareness of nutritional therapies, which is boosting the market growth.
In the Middle East and Africa, the demand is primarily driven by the rising prevalence of stevia which leads to high rates of nutritional deficiencies and diseases like diabetes. In addition, health check-ups in certain parts of the region, enhance the use of nutritional products to manage these diseases. Furthermore, continuous investments in programs focusing on healthcare and nutrition are contributing to the market expansion.
Some of the leading medical foods market companies include Abbott Healthcare Private Limited, Alfasigma S.p.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company LLC (Reckitt Benckiser), Medtrition Inc., Meiji Holdings Co. Ltd., Metagenics Inc. (Alticor), Nestlé S.A., Primus Pharmaceuticals Inc., Targeted Medical Pharma Inc., and Victus Inc., among many others.
Report Features | Details |
---|---|
Market Size in 2024 | USD 24.5 Billion |
Market Forecast in 2033 | USD 37.4 Billion |
Market Growth Rate 2025-2033 | 4.78% |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Products Covered | Pills, Powder, Others |
Route of Administrations Covered | Oral, Enteral |
Applications Covered | ADHD, Depression, Diabetes, Cancer, Alzheimer's Disease, Metabolic Disorders, Others |
Distribution Channels Covered | Supermarkets, Hospital and Retail Pharmacies, Online Pharmacies, Others |
Regions Covered | North America, Asia Pacific, Europe, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, China, Japan, India, South Korea, Australia, Indonesia, Germany, France, United Kingdom, Italy, Spain, Russia, Brazil, Mexico |
Companies Covered | Abbott Healthcare Private Limited, Alfasigma S.p.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company LLC (Reckitt Benckiser), Medtrition Inc., Meiji Holdings Co. Ltd., Metagenics Inc. (Alticor), Nestlé S.A., Primus Pharmaceuticals Inc., Targeted Medical Pharma Inc., Victus Inc., etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |